Professor Mark Morrison
Professor

Mark Morrison

Email: 
Phone: 
+61 7 344 36957

Availability

Professor Mark Morrison is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Clinical microbiology Clinical sciences Gastroenterology and hepatology Medical biochemistry and metabolomics Medical microbiology

Qualifications

  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

Search Professor Mark Morrison’s works on UQ eSpace

401 works between 1990 and 2025
All (401) Journal Article (245) Conference Publication (148) Book Chapter (8)

81 - 100 of 401 works

2022

Conference Publication

The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study

Kang, S., Teh, J. J., Schooth, L., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Ching, J. Y. L., Lin, W., Trakman, G. L., Sung, J., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2022). The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study

2022

Conference Publication

Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study

Hu, J., Ruan, Y., Lin, W., Trakman, G., Zhang, J., Teh, J. J., Kang, S., Hamilton, A., Wilson-O'Brien, A., Ching, J. Y. L., Sung, J. J. Y., Yu, J., Morrison, M., Kamm, M. A. and Ng, S. C. (2022). Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study

2022

Conference Publication

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

Schooth, L., Sid-Ahmed, A., Kang, S., Lim, Y., Fairlie, T., Shah, A., Holtmann, G. and Morrison, M. (2022). Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

2022

Conference Publication

Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study

Teh, J. J., Kang, S., Zhang, J., Hu, J., Hamilton, A., Wilson-O'Brien, A., Ching, J. Y. L., Lin, W., Trakman, G., Sung, J., Jun, Y., Ng, S., Kamm, M. and Morrison, M. (2022). Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study

2022

Journal Article

Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study

Matsuyama, Misa, Murtaza, Nida, Morrison, Mark, Davies, Peter S. W., Hill, Rebecca J. and Loughman, Amy (2022). Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 189 (7-8), 285-292. doi: 10.1002/ajmg.b.32915

Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study

2022

Journal Article

Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis

Shah, Ayesha, Thite, Parag, Hansen, Teressa, Kendall, Bradley J., Sanders, David S., Morrison, Mark, Jones, Michael P. and Holtmann, Gerald (2022). Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 37 (10), 1844-1852. doi: 10.1111/jgh.15920

Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis

2022

Journal Article

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study

Mak, Joyce W. Y., Yang, Sun, Stanley, Annalise, Lin, Xiaoqing, Morrison, Mark, Ching, Jessica Y. L., Niu, Junkun, Wilson-O'Brien, Amy L., Feng, Rui, Tang, Whitney, Hamilton, Amy L., Or, Leo, Trakman, Gina L., Lin, Winnie Y. Y., Sung, Joseph J. Y., Chen, Ming Hu, Mao, Yinglei, Kamm, Michael A. and Ng, Siew C. (2022). Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study. JGH Open, 6 (6), 369-377. doi: 10.1002/jgh3.12755

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study

2022

Conference Publication

Strain-level resolution of the colonic mucosa-associated microbiota reveals novel trans-ethnic differences in health and Crohn's disease. The ENIGMA study

Teh, Jing Jie, Kang, Seungha, Zhang, Jingwan, Hu, Jielun, Hamilton, Amy L., Wilson-O'Brien, Amy, Ching, Jessica Y., Lin, Winnie Y., Trakman, Gina L., Sung, Joseph, Yu, Jun, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2022). Strain-level resolution of the colonic mucosa-associated microbiota reveals novel trans-ethnic differences in health and Crohn's disease. The ENIGMA study. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)62327-8

Strain-level resolution of the colonic mucosa-associated microbiota reveals novel trans-ethnic differences in health and Crohn's disease. The ENIGMA study

2022

Conference Publication

Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing

Schooth, Lauren F., Ahmed, Ahmed Sid, Kang, Seungha, Shah, Ayesha, Fairlie, Thomas, Teh, Jing Jie, Lim, Yenkai, Hoedt, Emily C., Talley, Nicholas J., Keely, Simon, Holtmann, Gerald J. and Morrison, Mark (2022). Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)61208-3

Strain-level functional and phenotypic resolution of the duodenal mucosa-associated microbiota in functional dyspepsia and healthy control subjects via a novel ex vivo combination of microbe culture and metagenomic sequencing

2022

Conference Publication

Deep characterization of the mucosa-associated microbiota in asian and western populations reveals acidaminococcus occupies a key niche in the nitrogen economy of Crohn's disease. The ENIGMA study

Drljaca, Sonja, Vollenbroich, Valeria, Teh, Jing Jie, Kang, Seungha, Zhang, Jingwan, Hu, Jielun, Hamilton, Amy L., Wilson-O'Brien, Amy, Ching, Jessica Y., Lin, Winnie Y., Trakman, Gina L., Sung, Joseph, Yu, Jun, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2022). Deep characterization of the mucosa-associated microbiota in asian and western populations reveals acidaminococcus occupies a key niche in the nitrogen economy of Crohn's disease. The ENIGMA study. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)60319-6

Deep characterization of the mucosa-associated microbiota in asian and western populations reveals acidaminococcus occupies a key niche in the nitrogen economy of Crohn's disease. The ENIGMA study

2022

Conference Publication

Influence of proton pump inhibitors on the mucosa associated microbiome in the small intestine and colon

Shah, Ayesha, Sternes, Peter R., Pintos, Camila Ayala, Kang, Seungha, Jones, Michael P., Tyson, Gene, Morrison, Mark and Holtmann, Gerald J. (2022). Influence of proton pump inhibitors on the mucosa associated microbiome in the small intestine and colon. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)62401-6

Influence of proton pump inhibitors on the mucosa associated microbiome in the small intestine and colon

2022

Conference Publication

Food additives intake is associated with microbiome dysbiosis and specific pro-inflammatory bacterial changes in Crohn's disease. The ENIGMA study

Zhang, Jingwan, Sun, Qianru, Teh, Jing Jie, Kang, Seungha, Hu, Jielun, Lin, Winnie Y., Trakman, Gina L., Hamilton, Amy L., Brien, Amy Wilson O’, Ching, Jessica Y., Sung, Joseph JY, Yu, Jun, Morrison, Mark, Kamm, Michael A. and Ng, Siew C. (2022). Food additives intake is associated with microbiome dysbiosis and specific pro-inflammatory bacterial changes in Crohn's disease. The ENIGMA study. American Gastroenterological Association Conference 2022, Chicago, IL United States, 6-9 May 2022. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(22)60218-x

Food additives intake is associated with microbiome dysbiosis and specific pro-inflammatory bacterial changes in Crohn's disease. The ENIGMA study

2022

Journal Article

Skin cancer-associated S. aureus strains can induce DNA damage in human keratinocytes by downregulating DNA repair and promoting oxidative stress

Krueger, Annika, Mohamed, Ahmed, Kolka, Cathryn M., Stoll, Thomas, Zaugg, Julian, Linedale, Richard, Morrison, Mark, Soyer, H. Peter, Hugenholtz, Philip, Frazer, Ian H. and Hill, Michelle M. (2022). Skin cancer-associated S. aureus strains can induce DNA damage in human keratinocytes by downregulating DNA repair and promoting oxidative stress. Cancers, 14 (9) 2143, 2143. doi: 10.3390/cancers14092143

Skin cancer-associated S. aureus strains can induce DNA damage in human keratinocytes by downregulating DNA repair and promoting oxidative stress

2022

Journal Article

Secreted NF-κB suppressive microbial metabolites modulate gut inflammation

Giri, Rabina, Hoedt, Emily C., Khushi, Shamsunnahar, Salim, Angela A., Bergot, Anne-Sophie, Schreiber, Veronika, Thomas, Ranjeny, McGuckin, Michael A., Florin, Timothy H., Morrison, Mark, Capon, Robert J., Ó Cuív, Páraic and Begun, Jakob (2022). Secreted NF-κB suppressive microbial metabolites modulate gut inflammation. Cell Reports, 39 (2) 110646, 110646. doi: 10.1016/j.celrep.2022.110646

Secreted NF-κB suppressive microbial metabolites modulate gut inflammation

2022

Journal Article

Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study

Chan, Samuel, Hawley, Carmel M., Pascoe, Elaine M., Cao, Christopher, Campbell, Scott B., Campbell, Katrina L., Francis, Ross S., Hale, Rachael, Isbel, Nicole M., Morrison, Mark and Johnson, David W. (2022). Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study. Journal of Renal Nutrition, 106 (9S), 718-725. doi: 10.1053/j.jrn.2022.02.006

Prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset: a randomized controlled feasibility study

2022

Journal Article

Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients

Krueger, Annika, Zaugg, Julian, Lachner, Nancy, Bialasiewicz, Seweryn, Lin, Lynlee L., Gabizon, Sharon, Sobarun, Priyamvada, Morrison, Mark, Soyer, H. Peter, Hugenholtz, Philip and Frazer, Ian H. (2022). Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients. ISME Communications, 2 (1) 13, 13. doi: 10.1038/s43705-022-00095-7

Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients

2022

Journal Article

Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin

Krueger, Annika, Zaugg, Julian, Chisholm, Sarah, Linedale, Richard, Lachner, Nancy, Teoh, Siok Min, Tuong, Zewen K., Lukowski, Samuel W., Morrison, Mark, Soyer, H. Peter, Hugenholtz, Philip, Hill, Michelle M. and Frazer, Ian H. (2022). Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin. Frontiers in Microbiology, 12 789042, 789042. doi: 10.3389/fmicb.2021.789042

Secreted toxins from Staphylococcus aureus strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin

2022

Journal Article

Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis

Movva, Ramya, Murtaza, Nida, Giri, Rabina, Png, Chin Wen, Davies, Julie, Alabbas, Saleh, Oancea, Iulia, O'Cuiv, Páraic, Morrison, Mark, Begun, Jakob and Florin, Timothy H. (2022). Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis. Gastro Hep Advances, 1 (3), 359-374. doi: 10.1016/j.gastha.2021.12.008

Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis

2021

Journal Article

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Kelly, Jaimon T., Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial. Nutrients, 13 (12) 4481, 4481. doi: 10.3390/nu13124481

Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): a feasibility randomized controlled trial

2021

Journal Article

Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease

McFarlane, Catherine, Krishnasamy, Rathika, Stanton, Tony, Savill, Emma, Snelson, Matthew, Mihala, Gabor, Morrison, Mark, Johnson, David W. and Campbell, Katrina L. (2021). Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease. Journal of Renal Nutrition, 32 (5), 542-551. doi: 10.1053/j.jrn.2021.10.003

Diet quality and protein-bound uraemic toxins: investigation of novel risk factors and the role of microbiome in chronic kidney disease

Current funding

  • 2025 - 2026
    Metabolomic signatures of the duodenal mucosa associated microbiota in Primary Sclerosing Cholangitis (PSC) and its associated Inflammatory Bowel Disease (IBD)
    University of Newcastle
    Open grant
  • 2024 - 2029
    Centre of Research Excellence in Transforming Gut Health (a 2024 NHMRC Centres of Research Excellence grant led by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2024 - 2027
    Harnessing microbial immunomodulatory function to improve treatment of inflammatory bowel diseases
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2026
    Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease (NHMRC Investigator Grant led by CI Kamm University of Melbourne)
    University of Melbourne
    Open grant
  • 2021 - 2025
    Drugs from Bugs: Developing New Inflammatory Bowel Disease Drugs from Gut Bacteria-Derived Bioactives
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2021 - 2025
    Bringing Archaeal biodiversity to life from native Australian herbivores
    ARC Discovery Projects
    Open grant
  • 2020 - 2025
    Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for... (MRFF EPCDR Endometriosis Grant led by Monash)
    Monash University
    Open grant

Past funding

  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2023 - 2024
    Responses of duodenal spheroid cultures to the secretomes of duodenal microbiota from patients with and without disorders of gut brain interactions (NHMRC CRE led by University of Newcastle)
    University of Newcastle
    Open grant
  • 2023 - 2025
    Investigating gastrointestinal biofilms regarding biochemistry and links with clinical manifestations (2023 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Research Support Scheme Co-funded Collaboration Grant
    Open grant
  • 2022 - 2023
    The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms
    Bayer - Steigerwald Arzneimittelwerk GmbH
    Open grant
  • 2022
    Linking the presence of live Ileal-derived bacteria in the joint as a triggering factor for the development of Spondyloarthropathy.
    Arthritis Foundation of Australia
    Open grant
  • 2021 - 2022
    Impacts of food additives on the duodenal mucosa-associated microbiota
    University of Newcastle
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Comparative Genomic Sequencing of selected strains of probiotic bacteria - Phase II
    Innovation Connections
    Open grant
  • 2020 - 2021
    Functionally characterizing IBD dysbiosis and harnessing gut bioactives to suppress IL-23 driven inflammation
    The Global Grants for Gut Health
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2019 - 2020
    Comparative Genomic Sequencing of selected strains of probiotic bacteria
    Innovation Connections
    Open grant
  • 2017 - 2020
    Invention of a Genetic Toolkit for Immunomodulatory Gut Bacteria to Expedite the Development of New Crohn's Disease Therapeutics
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2017 - 2018
    Prebiotic Study of Faecal Samples - Using Diets Rich in Dietary Fibre to Improve Bowel Habit and Sense of Wellbeing
    Monash University
    Open grant
  • 2017 - 2022
    The ENIGMA project: Eastern Inflammatory Bowel Disease Gut Microbiota
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2017 - 2020
    Epithelial metabolism as a mediator of host-microbiome interactions in inflammatory bowel disease (NHMRC Project Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2017 - 2018
    Linking maternal and infant microbiome: effects of GDM or effects of probiotics?
    Diabetes Australia Research Program
    Open grant
  • 2016 - 2019
    Rapid functional and taxonomic skin microbe characterisation
    ARC Linkage Projects
    Open grant
  • 2016 - 2020
    Design rules for nutritionally-functional grains
    ARC Linkage Projects
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Modification of the microbiome to protect against spondyloarthropathy in SKG mice
    Arthritis Foundation of Australia
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Microbiome in highly trained athletes and response to dietary change
    Australian Institute Sport
    Open grant
  • 2015
    Design rules for nutritionally-functional starches
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2015 - 2017
    Evolution of the marsupial gut microbiome and adaptation to eucalypt toxins
    ARC Discovery Projects
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Your microbiome or your mother's? The relationship between the microbiomes of mothers and babies
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Bringing genomes to life: isolation of genetically tractable, not-yet-cultured members of the human microbiota using metaparental mating methods
    PA Research Foundation
    Open grant
  • 2014 - 2018
    Determinants of progression of actinic keratoses to squamous cancer
    NHMRC Project Grant
    Open grant

Availability

Professor Mark Morrison is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Professor Mark Morrison's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au